News Notes

Move over golden rice, genetically modified cats are in the works. Syracuse, N.Y., residents Jackie and David Avner, among the 10 percent of the population who have cat allergies, are working to create a feline that won't make their eyes water. Their privately held company, Transgenic Pets LLC (www.transgenicpets.com) is using knockout technology to create kitties that are missing the sole human allergen. David Avner, an emergency medicine physician, got the idea about seven years ago, according

Written byRicki Lewis
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share
Move over golden rice, genetically modified cats are in the works. Syracuse, N.Y., residents Jackie and David Avner, among the 10 percent of the population who have cat allergies, are working to create a feline that won't make their eyes water. Their privately held company, Transgenic Pets LLC (www.transgenicpets.com) is using knockout technology to create kitties that are missing the sole human allergen. David Avner, an emergency medicine physician, got the idea about seven years ago, according to Jackie. "He was testing ways to lower exposure to pet allergens in the home--specialized vacuum cleaners, air filters, and various ways to bathe cats," she says. "His conclusion was that they weren't effective. One evening, he thought, why not just remove the allergen at its source?" The knocked out cat gene encodes a protein that does not seem vital to feline health. Dogs, in contrast, produce several allergens. In 1995, David Avner applied for a patent to create an allergen- free knockout transgenic cat. The genetic modification is proceeding under the experienced hands of Xiangzhong (Jerry) Yang, head of the University of Connecticut, Storrs, Transgenic Animal Facility. Yang's team has cloned calves and created transgenic pigs, rabbits, and rodents, and hopes to add cats to the list by 2003. The initial animals can be interbred. Why custom-made kitties when shelters are overstocked? "We're looking to provide pets for people unable to have them," Jackie Avner says. The first altered cats, according to the Web site, will go "at a premium;" then the cost should dip to $750 to $1000.

USDA Launches Food Safety Web Site

The U.S. Department of Agriculture recently launched a new Internet Web site devoted to food safety (www.nal.usda.gov/fsrio/). In 1997, Congress mandated the department's Food Safety Research Information Office (FSRIO)--housed in the Library of Agriculture in Beltsville, Md.--to "provide to the research community and the general public information on publicly funded, and to the extent possible, privately funded, food safety research initiatives." The new Web site aims to disseminate that information. FSRIO, says coordinator Yvette Alonso, will "collect all information and thereby avoid duplication of efforts" by other agencies that include food safety in their portfolios. So far, the site supplies research data from USDA and the Food and Drug Administration. FSRIO hopes to get other federal sources, including the National Institutes of Health, National Science Foundation, Environmental Protection Agency and Centers for Disease Control and Prevention online soon. Says Alonso, "Even NASA has some food safety projects we want." She'll also acquire information from state, university, private sector, and foreign sources, but she admits that with all the interest and a staff of just three people, "we'll have to prioritize our efforts." FSRIO provides links to other food-safety Web sites plus a search engine that turns up summaries of relevant research initiatives.
--Barry A. Palevitz

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies